Continuous versus bolus norepinephrine during anesthesia induction for postinduction hypotension
Official title: Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension in High-Risk Non-Cardiac Surgery Patients - The Multicenter INDUCT Trial (INDUCT-Multi)
Run by Universitätsklinikum Hamburg-Eppendorf · NCT07538388 · Data updated 2026-11-12
This trial will test whether giving norepinephrine as a continuous infusion instead of repeated boluses during induction of general anesthesia reduces low blood pressure in high-risk non-cardiac surgery patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 446 (estimated) |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 4 sites (Berlin and 3 other locations) |
| Status | Recruiting |
| Started | May 7, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07538388 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are consenting adults (≥45 years) scheduled for elective major non-cardiac surgery with planned continuous radial arterial blood pressure monitoring and at least two specified risk factors for perioperative acute kidney injury.
✕Probably not a fit
Patients unlikely to benefit include those with a clinical indication for continuous norepinephrine already, active cardiac arrhythmias, pregnancy, certain intracranial conditions, or those unable to consent in German or who will not have arterial line monitoring.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
INDUCT-Multi is a multicenter, randomized comparison of continuous norepinephrine infusion versus repeated bolus dosing started during induction of general anesthesia. The trial enrolls consenting patients aged 45 and older having elective major non-cardiac surgery who will have radial arterial catheter monitoring and carry predefined risk factors for acute kidney injury. Continuous arterial blood pressure monitoring is used during induction and the assigned norepinephrine strategy is applied to maintain blood pressure. The main focus is on reducing the frequency and severity of postinduction hypotension, with secondary interest in downstream organ injury such as acute kidney injury and overall hemodynamic stability.
Why it matters
Potential benefit: If successful, this approach could produce more stable blood pressure during induction and reduce episodes of severe hypotension and related complications such as acute kidney injury.
How similar studies have gone: A prior single-center randomized trial showed improved blood pressure stability with continuous norepinephrine, but multicenter confirmation is limited and this trial seeks broader validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: We will include consenting patients ≥45 years scheduled for elective non-cardiac surgery under general anesthesia with planned continuous intra-arterial blood pressure monitoring with a radial arterial catheter and with at least two of the following risk criteria for developing acute kidney injury: * Age ≥65 years * ASA physical status III or IV * Chronic arterial hypertension * Diabetes mellitus requiring medication * Intra-abdominal surgery * Preoperative renal insufficiency (serum creatinine ≥1.2 mg/dL) Exclusion Criteria: * Pregnancy * Cardiac arrhythmia * History of intracranial hemorrhage or intracranial aneurysm * Clinical indication for continuous norepinephrine infusion during induction of general anesthesia (e.g., severe aortic valve stenosis, coronary artery disease, or heart failure) * Patients who are unable to understand, read, and provide informed consent in German
Where it's running
-
Department of Anesthesiology, University Hospital Duesseldorf, Heinrich Heine University Duesseldorf
Düsseldorf, Germany Recruiting -
Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf
Hamburg, Germany Recruiting -
Department of Anaesthesiology, University Hospital LMU Munich
München, Germany Recruiting -
Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin
Berlin, Germany Not yet recruiting
Study contacts
- Study coordinator: Kristen K Thomsen, MD
- Email: kr.thomsen@uke.de
- Phone: +4940741070215
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intermittent Ephedrine Boluses to Prevent Postinduction Hypotension in High-Risk Major Abdominal Surgery
This trial tests whether giving small, regular ephedrine doses around induction can prevent low blood pressure after anesthesia in older, higher-risk patients undergoing major abdominal surgery.
-
ADBest TREAT Registry for adults with atopic dermatitis
A registry in Germany is collecting real-world data from adults with atopic dermatitis to see how treatments are used and how the disease affects quality of life.
-
Robot-assisted sleeve gastrectomy with Hugo system feasibility
This study tests whether sleeve gastrectomy can be safely done using the Hugo robotic system in adults with severe obesity.
-
Keep blood pressure at 85 or more during surgery to prevent delirium in older adults with hypertension
In older adults with high blood pressure undergoing non-heart surgery, researchers test if keeping mean arterial pressure at or above 85 mmHg during surgery reduces postoperative delirium.
-
Intergenerational Mentoring to Reduce Loneliness and Improve Well-Being
This project tests intergenerational mentoring between seniors 60+ and youths aged 12–21 in Hamburg to see if it reduces loneliness and improves mental well-being and quality of life.
-
30-minute cycling immediately before nivolumab and ipilimumab for metastatic melanoma
This trial will test whether a 30-minute cycling session immediately before nivolumab plus ipilimumab boosts immune activity and improves outcomes for people with metastatic melanoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.